B lymphocytes in humans express ZAP-70 when activated in vivo

被引:55
作者
Cutrona, G [1 ]
Colombo, M
Matis, S
Reverberi, D
Dono, M
Tarantino, V
Chiorazzi, N
Ferrarini, M
机构
[1] IST, Ist Nazl Ric Cancro, Div Med Oncol C, I-16132 Genoa, Italy
[2] Univ Genoa, Dept Oncol Biol & Genet, Genoa, Italy
[3] Ist Giannina Gaslini, Dept Otolaryngol, Genoa, Italy
[4] N Shore Univ Hosp, Dept Med, Manhasset, NY USA
[5] Albert Einstein Coll Med, Dept Med, Bronx, NY USA
[6] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY USA
关键词
activated B cells; B cells subsets; B-CLL; human B lymphocytes; ZAP-70;
D O I
10.1002/eji.200526355
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ZAP-70 is a protein tyrosine kinase initially found in T and NK cells. Recently, this important signaling element was detected in leukemic B cells from a subgroup of patients with B cell chronic lymphocytic leukemia (B-CLL). In this study, ZAP-70 was detected in normal B cells from human tonsils, but not from peripheral blood. The cDNA sequence of B cell ZAP-70 was the same as that in T cells. Germinal center B cells and plasma cells had a substantial proportion of ZAP-70(+) cells, while memory and follicular mantle B cells, which contain low numbers of activated B cells, expressed relatively little ZAP-70. A cell fraction of IgD(+), CD38(+) B cells, which are comprised of many in vivo activated B cells, exhibited the highest levels of ZAP-70. Density gradient fractionation of tonsil B cells confirmed that ZAP-70 was not expressed by resting B cells, but was expressed by buoyant, in vivo activated B cells. In these B cells, the expression of ZAP-70 correlated with that of CD38 and not with that of CD5, a hallmark of B-CLL cells. B-CLL. cells are activated cells and their ZAP-70 expression reflects a normal property of activated B cells populations rather than a neoplastic aberration.
引用
收藏
页码:558 / 569
页数:12
相关论文
共 32 条
[1]   Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma [J].
Admirand, JH ;
Rassidakis, GZ ;
Abruzzo, LV ;
Valbuena, JR ;
Jones, D ;
Medeiros, LJ .
MODERN PATHOLOGY, 2004, 17 (08) :954-961
[2]   B cell subpopulations separated by CD27 and crucial collaboration of CD27(+) B cells and helper T cells in immunoglobulin production [J].
Agematsu, K ;
Nagumo, H ;
Yang, FC ;
Nakazawa, T ;
Fukushima, K ;
Ito, S ;
Sugita, K ;
Mori, T ;
Kobata, T ;
Morimoto, C ;
Komiyama, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (08) :2073-2079
[3]   Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasms [J].
Carreras, J ;
Villamor, N ;
Colomo, L ;
Moreno, C ;
Cajal, SRY ;
Crespo, M ;
Tort, F ;
Bosch, F ;
López-Guillermo, A ;
Colomer, D ;
Montserrat, E ;
Campo, E .
JOURNAL OF PATHOLOGY, 2005, 205 (04) :507-513
[4]   ZAP-70 - A 70 KD PROTEIN-TYROSINE KINASE THAT ASSOCIATES WITH THE TCR ZETA-CHAIN [J].
CHAN, AC ;
IWASHIMA, M ;
TURCK, CW ;
WEISS, A .
CELL, 1992, 71 (04) :649-662
[5]   ZAP-70 directly enhances TgM signaling in chronic lymphocytic leukemia [J].
Chen, LG ;
Apgar, J ;
Huynh, L ;
Dicker, F ;
Giago-McGahan, T ;
Rassenti, L ;
Weiss, A ;
Kipps, TJ .
BLOOD, 2005, 105 (05) :2036-2041
[6]   Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia [J].
Chen, LG ;
Widhopf, G ;
Huynh, L ;
Rassenti, L ;
Rai, KR ;
Weiss, A ;
Kipps, TJ .
BLOOD, 2002, 100 (13) :4609-4614
[7]   B cell chronic lymphocytic leukemia: Lessons learned from studies of the B cell antigen receptor [J].
Chiorazzi, N ;
Ferrarini, M .
ANNUAL REVIEW OF IMMUNOLOGY, 2003, 21 :841-894
[8]   Mechanisms of disease: Chronic lymphocytic leukemia [J].
Chiorazzi, N ;
Rai, KR ;
Ferrarini, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08) :804-815
[9]   ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia [J].
Crespo, M ;
Bosch, F ;
Villamor, N ;
Bellosillo, B ;
Colomer, D ;
Rozman, M ;
Marcé, S ;
López-Guillermo, A ;
Campo, E ;
Montserrat, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (18) :1764-1775
[10]   Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia [J].
Damle, RN ;
Wasil, T ;
Fais, F ;
Ghiotto, F ;
Valetto, A ;
Allen, SL ;
Buchbinder, A ;
Budman, D ;
Dittmar, K ;
Kolitz, J ;
Lichtman, SM ;
Schulman, P ;
Vinciguerra, VP ;
Rai, KR ;
Ferrarini, M ;
Chiorazzi, N .
BLOOD, 1999, 94 (06) :1840-1847